D. Cook

发表

Identification of amidoheteroaryls as potent inhibitors of mutant (V600E) B-Raf kinase with in vivo activity.

David A. Scott, P. Lyne, L. Drew, 2009, Bioorganic & medicinal chemistry letters.

Identification of 3-amido-4-anilinoquinolines as potent and selective inhibitors of CSF-1R kinase.

David A. Scott, Audrey M Davies, M. Zinda, 2009, Bioorganic & medicinal chemistry letters.

Pyridyl and thiazolyl bisamide CSF-1R inhibitors for the treatment of cancer.

David A. Scott, P. Lyne, B. Aquila, 2008, Bioorganic & medicinal chemistry letters.

Facile Synthesis of a Simplified Bicyclo[7.3.1] Esperamicin-Calicheamicin Enediyne Core

D. Langley, J. Kadow, T. Doyle, 1994 .

Discovery of a novel class of dimeric Smac mimetics as potent IAP antagonists resulting in a clinical candidate for the treatment of cancer (AZD5582).

E. Hennessy, V. Oza, B. Aquila, 2013, Journal of medicinal chemistry.

Discovery and optimization of a novel series of potent mutant B-Raf(V600E) selective kinase inhibitors.

Allan Wu, Edward Hennessy, Jon Read, 2013, Journal of medicinal chemistry.

Synthesis of tritium labeled (±) 15-deoxyspergualin trihydrochloride

M. Saulnier, M. Tepper, D. Cook, 1993 .

Synthesis and biological activity of macrocyclic taxane analogues.

James G. Tarrant, C. Fairchild, J. Kadow, 2004, Bioorganic & medicinal chemistry letters.

3-amido-4-anilinoquinolines as CSF-1R kinase inhibitors 2: Optimization of the PK profile.

David A. Scott, L. Drew, L. Dakin, 2009, Bioorganic & medicinal chemistry letters.

The discovery of BMS-275183: an orally efficacious novel taxane.

James G. Tarrant, C. Fairchild, J. Kadow, 2003, Bioorganic & medicinal chemistry.

Identification of 3-amido-4-anilinoquinolines as potent and selective inhibitors of CSF-1R kinase.

David A. Scott, Audrey M Davies, M. Zinda, 2009, Bioorganic & medicinal chemistry letters.